AAAAAA

   
Results: 1-21 |
Results: 21
Thymic expression of insulin-related genes in an animal model of autoimmune type 1 diabetes
Authors: Kecha-Kamoun, O Achour, I Martens, H Collette, J Lefebvre, PJ Greiner, DL Geenen, V
Citation: O. Kecha-kamoun et al., Thymic expression of insulin-related genes in an animal model of autoimmune type 1 diabetes, DIABET M R, 17(2), 2001, pp. 146-152
Obesity: causes and new treatments
Authors: Lefebvre, PJ Scheen, AJ
Citation: Pj. Lefebvre et Aj. Scheen, Obesity: causes and new treatments, EXP CL E D, 109, 2001, pp. S215-S224
Risk of developing retinopathy in diabetes control and complications trialtype 1 diabetic patients with good or poor metabolic control
Authors: Zhang, LY Krzentowski, G Albert, A Lefebvre, PJ
Citation: Ly. Zhang et al., Risk of developing retinopathy in diabetes control and complications trialtype 1 diabetic patients with good or poor metabolic control, DIABET CARE, 24(7), 2001, pp. 1275-1279
Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats
Authors: Damas, J Hallet, C Lefebvre, PJ
Citation: J. Damas et al., Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats, BR J PHARM, 134(6), 2001, pp. 1312-1318
Antiobesity pharmacotherapy in the management of Type 2 diabetes
Authors: Scheen, AJ Lefebvre, PJ
Citation: Aj. Scheen et Pj. Lefebvre, Antiobesity pharmacotherapy in the management of Type 2 diabetes, DIABET M R, 16(2), 2000, pp. 114-124
Non-alcoholic steatohepatitis: Association with obesity and insulin resistance, and influence of weight loss
Authors: Luyckx, FH Lefebvre, PJ Scheen, AJ
Citation: Fh. Luyckx et al., Non-alcoholic steatohepatitis: Association with obesity and insulin resistance, and influence of weight loss, DIABETE MET, 26(2), 2000, pp. 98-106
Assessment of postprandial hepatic glycogen synthesis from uridine diphosphoglucose kinetics in obese and lean non-diabetic subjects
Authors: Paquot, N Schneiter, P Scheen, AJ Lefebvre, PJ Tappy, L
Citation: N. Paquot et al., Assessment of postprandial hepatic glycogen synthesis from uridine diphosphoglucose kinetics in obese and lean non-diabetic subjects, INT J OBES, 24(10), 2000, pp. 1297-1302
No increased insulin sensitivity after a single intravenous administrationof a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients
Authors: Paquot, N Castillo, MJ Lefebvre, PJ Scheen, AJ
Citation: N. Paquot et al., No increased insulin sensitivity after a single intravenous administrationof a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients, J CLIN END, 85(3), 2000, pp. 1316-1319
Insulin resistance vs. insulin deficiency: Which comes first? The old question revisited
Authors: Scheen, AJ Lefebvre, PJ
Citation: Aj. Scheen et Pj. Lefebvre, Insulin resistance vs. insulin deficiency: Which comes first? The old question revisited, DIABETES IN THE NEW MILLENNIUM, 2000, pp. 101-113
State of current therapy and patient care in Europe
Authors: Lefebvre, PJ Scheen, AJ
Citation: Pj. Lefebvre et Aj. Scheen, State of current therapy and patient care in Europe, INT J CL PR, 1999, pp. 6-10
Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on abasal-bolus insulin scheme
Authors: Scheen, AJ Letiexhe, MR Lefebvre, PJ
Citation: Aj. Scheen et al., Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on abasal-bolus insulin scheme, DIABETE MET, 25(2), 1999, pp. 157-162
Management of the obese diabetic patient
Authors: Scheen, AJ Lefebvre, PJ
Citation: Aj. Scheen et Pj. Lefebvre, Management of the obese diabetic patient, DIABET REV, 7(2), 1999, pp. 77-93
Insulin sensitivity, clearance and release in kininogen-deficient rats
Authors: Damas, J Bourdon, V Lefebvre, PJ
Citation: J. Damas et al., Insulin sensitivity, clearance and release in kininogen-deficient rats, EXP PHYSIOL, 84(3), 1999, pp. 549-557
Pharmacological treatment of obesity: present status
Authors: Scheen, AJ Lefebvre, PJ
Citation: Aj. Scheen et Pj. Lefebvre, Pharmacological treatment of obesity: present status, INT J OBES, 23, 1999, pp. 47-53
Troglitazone: Antihyperglycemic activity and potential role in the treatment of type 2 diabetes
Authors: Scheen, AJ Lefebvre, PJ
Citation: Aj. Scheen et Pj. Lefebvre, Troglitazone: Antihyperglycemic activity and potential role in the treatment of type 2 diabetes, DIABET CARE, 22(9), 1999, pp. 1568-1577
Non-alcoholic steatohepatitis
Authors: Luyckx, FH Scheen, AJ Lefebvre, PJ
Citation: Fh. Luyckx et al., Non-alcoholic steatohepatitis, LANCET, 354(9186), 1999, pp. 1298-1299
Parallel reversibility of biological markers of the metabolic syndrome andliver steatosis after gastroplasty-induced weight loss in severe obesity
Authors: Luyckx, FH Scheen, AJ Desaive, C Thiry, A Lefebvre, PJ
Citation: Fh. Luyckx et al., Parallel reversibility of biological markers of the metabolic syndrome andliver steatosis after gastroplasty-induced weight loss in severe obesity, J CLIN END, 84(11), 1999, pp. 4293-4293
Glucose metabolism and the postprandial state
Authors: Lefebvre, PJ Scheen, AJ
Citation: Pj. Lefebvre et Aj. Scheen, Glucose metabolism and the postprandial state, EUR J CL IN, 29, 1999, pp. 1-6
The EASD at the crossroads
Authors: Lefebvre, PJ
Citation: Pj. Lefebvre, The EASD at the crossroads, DIABETOLOG, 42(12), 1999, pp. 1381-1382
Severe/extreme obesity: A medical disease requiring a surgical treatment?
Authors: Scheen, AJ Luyckx, FH Desaive, C Lefebvre, PJ
Citation: Aj. Scheen et al., Severe/extreme obesity: A medical disease requiring a surgical treatment?, ACT CLIN B, 54(3), 1999, pp. 154
The postprandial state and risk of cardiovascular disease
Authors: Lefebvre, PJ Scheen, AJ
Citation: Pj. Lefebvre et Aj. Scheen, The postprandial state and risk of cardiovascular disease, DIABET MED, 15(12), 1998, pp. S63-S68
Risultati: 1-21 |